| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1200 | ₹1,33,200 |
| HNI / NII | 2 | 2,400 | ₹2,66,400 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 10,26,000 (18.99%) | — | ₹1,138.86 Cr |
| NII / HNI (Total) | — | 20,53,200 (38.00% | — | ₹2,279.05 Cr |
| Retail Investors | — | 20,53,200 (38.00%) | — | ₹2,279.05 Cr |
| Total ** | — | 54,03,600 (100.00%) | — | ₹59,979.96 Cr |
| Market Maker * | — | 2,71,200 (5.02%) | — | ₹30.10 Cr |
| Metric | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 23.25 | 44.28 | 30.28 |
| PAT | 6.52 | 12.54 | 3.11 |
| EBITDA | — | — | — |
| Net Worth | 23.68 | 17.16 | 4.60 |
| Total Assets | 28.89 | 18.98 | 12.39 |
| Reserves | 8.08 | 17.11 | 4.57 |
| Borrowings | — | — | — |
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
Competitive Strength